Skip to main content
Log in

Synthesis of New Acetaminophen Analogs and Their Ibuprofen Conjugates as Novel Analgesic Drugs

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

In this research, new analogs of acetaminophen (paracetamol, I) with dimethyl and ethyl substitutions on phenyl moiety and sulfonamide modified by inserting alkylpiperazine derivatives were synthesized (II – V). Then, their conjugated compounds with ibuprofen were also synthesized (VI – IX) and the analgesic and anti-inflammatory activities of new drugs (II – IX) were evaluated in formalin tests on rats. Results indicated that the best analgesic activity was observed for compounds II and VI in diminishing chronic and VI – IX in acute thermal pain tests; in addition, compound VIII showed the best activity in diminishing inflammation. It was concluded that chemical structural binding of the potent synthesized drugs (II – V) with ibuprofen produced new superior antinociceptive and anti-inflammatory drugs (VI – IX) which could alleviate both pain and inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Scheme 2
Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. L. F. Prescott, Drugs, 25, 290 – 314 (1983).

    Article  CAS  PubMed  Google Scholar 

  2. O. Moling, E. Cairon, G. Rimenti, et al., Clin. Ther. 28, 755 – 760 (2006).

    Article  CAS  PubMed  Google Scholar 

  3. M. R. Yadav, D. M. Nimekar, A. Ananthakrishnan, et al., Bioorg. Med. Chem., 14, 8701 – 8706 (2006).

    Article  CAS  PubMed  Google Scholar 

  4. A. Bertolini, A. Ferrari, A. Ottani, et al., CNS Drug Rev., 12, 250 – 275 (2006).

    Article  CAS  PubMed  Google Scholar 

  5. A. N. Viswanathan, D. Feskanich, E. S. Schernhammer, and S. E. Hankinson, Cancer Res., 68, 2507 – 2513 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. M. A. Altinoz and R. Korkmaz, Neoplasma, 51, 239 – 247 (2004).

    CAS  PubMed  Google Scholar 

  7. B. Bryant, K. Knights, and E. Salerno, Pharmacology for Health Professionals, Elsevier, Australia (2006), p. 270.

    Google Scholar 

  8. A. L. Vaccarino, D. Paul, P. K. Mukherjee, et al., Bioorg. Med. Chem., 15, 2206 – 2215 (2007).

    Article  CAS  PubMed  Google Scholar 

  9. B. Hinz, O. Cheremina, and K. Brune, FASEB J., 22, 383 – 390 (2008).

    Article  CAS  PubMed  Google Scholar 

  10. A. S. Kalgutkar, A. B. Marnett, B. C. Crews, et al., J. Med. Chem., 43, 2860 – 2870 (2000).

    Article  CAS  PubMed  Google Scholar 

  11. M. L. Barbosa, G. M. Melo, Y. K. da Silva, et al., Eur. J. Med. Chem., 44, 3612 – 3620 (2009).

    Article  CAS  PubMed  Google Scholar 

  12. A. Ahmadi, M. Khalili, S. Ahmadian, et al., Pharm. Chem. J., 48 (2), 109 – 115 (2014).

    Article  CAS  Google Scholar 

  13. T. J. Reilly, J. Chem. Educ., 76, 1557 (1999).

    Article  CAS  Google Scholar 

  14. Chamberlain, Xylazine. http://www.inchem.org/documents/jecfa/jecmono/v38je03.htm.

  15. S. S. Padi and S. K. Kulkarni, Eur. J. Pharmacol., 601, 79 – 87(2008).

    Article  CAS  PubMed  Google Scholar 

  16. H. Hamura, M. Yoshida, K. Shimizu, et al., Jpn. J. Pharmacol., 83, 286 – 292 (2000).

    Article  CAS  PubMed  Google Scholar 

  17. D. Dubuisson and S. G. Dennis, Pain, 4, 161 – 174 (1977).

    Article  CAS  PubMed  Google Scholar 

  18. M. Gupta, U. K. Mazumder, P. Gomathi, and S. V. Thamil, BMC Complement. Altern. Med., 6, 36 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. R. L. Elliott and P. H. Ruehle, US Patent No. 4614798 (1986); Assignee: Vetamix, Shenandoah, Iowa.

  20. M. F. Cheng, H. M. Yu, B. W. Ko, et al., Org. Biomol. Chem., 4, 510 – 518 (2006).

    Article  CAS  PubMed  Google Scholar 

  21. J. R. Bales, J. K. Nicholson, and P. J. Sadler, Clin. Chem., 31, 757 – 762 (1985).

    CAS  PubMed  Google Scholar 

  22. Guideline 106: Control of Pain in Adults with Cancer, Sections 6.1 and 7.1.1, Scottish Intercollegiate Guidelines Network (SIGN), Scotland National Health Service (2008).

  23. B. Kis, J. A. Snipes, and D. W. Busija, J. Pharmacol. Exp. Ther., 315, 1 – 7 (2005).

    Article  CAS  Google Scholar 

  24. N. V. Chandrasekharan, H. Dai, and K. L. Roos, Proc. Natl. Acad. Sci. USA, 99, 13926 – 13931 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. C. N. Dewall, G. Macdonald, and G. D. Webster, Psychol. Sci., 21, 931 – 937 (2010).

    Article  PubMed  Google Scholar 

  26. A. Köfalvi, Alternative interacting sites and novel receptors for cannabinoid ligands, in Cannabinoids and the Brain, Springer-Verlag, Berlin (2008), pp. 131 – 160.

    Google Scholar 

  27. A. Ottani, S. Leone, and M. Sandrini, Eur. J. Pharmacol., 531, 280 – 281 (2006).

    Article  CAS  PubMed  Google Scholar 

  28. D. A. Andersson, C. Gentry, L. Alenmyr, et al., Nat. Commun., 2, 551 (2011).

    Article  PubMed  Google Scholar 

  29. S. Alshahrani, F. Fernandez-Conti, A. Araujo, and M. DiFulvio, J. Vis. Exp., 63, e3785 (2012).

    PubMed  Google Scholar 

  30. J. Muñoz, C. Navarro, V. Noriega, et al., Inflammopharmacology, 18, 65 – 71 (2010).

    Article  PubMed  Google Scholar 

  31. R. M. Rezende, D. S. França, G. B. Menezes, et al., Br. J. Pharmacol., 153, 760 – 768 (2008).

    Article  CAS  PubMed  Google Scholar 

  32. S. S. Ayoub, G. Pryce, M. P. Seed, et al., Drug Metab. Dispos., 39, 1689 – 1695 (2011).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was a research project at Islamic Azad University, Karaj Branch, Iran and authors would like to express their gratitude to it. They thank Fariba Ansari for her assistance with the pharmacological tests. They appreciate Mojtaba Chaichi, EFL educator at Safir English Language Academy, for proofreading the initial draft of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abbas Ahmadi.

Additional information

Conflict of Interest

This research is not a part of our normal lecturing, employment, consultation and involvement. No institution will require any rights from this work too. In addition, no patent has been applied. No commercial right has been given to any company and/or institution, or it will not be done later either.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmadi, A., Khalili, M., Sadeghi, S. et al. Synthesis of New Acetaminophen Analogs and Their Ibuprofen Conjugates as Novel Analgesic Drugs. Pharm Chem J 50, 369–376 (2016). https://doi.org/10.1007/s11094-016-1454-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-016-1454-6

Keywords

Navigation